[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PlaceboControl group: Adjuvant; Participants in this group will receive two doses (IM) of Adjuvant by 50% v/v concentation produced in RAZI institute 21 days apart followed by another dose in the form of nasal spray at day 51 (counted from day 0)", "treatment_type": "TODO", "pharmacological_treatment": "Placebo"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIntervention group 3: Vaccine at 20 \u03bcg\u2044200\u03bcl dose; Participants in this group will receive two doses (IM) of RAZI recombinant spike protein vaccine 21 days apart followed by a 10 \u03bcg\u2044200\u03bcl nasal spray 51 days after the first dose (day 0)", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIntervention group 2: Vaccine at 10 \u03bcg\u2044200\u03bcl dose; Participants in this group will receive two doses (IM) of RAZI recombinant spike protein vaccine 21 days apart followed by a 10 \u03bcg\u2044200\u03bcl nasal spray 51 days after the first dose (day 0)", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIntervention group 1: Vaccine at 5 \u03bcg\u2044200\u03bcl dose; Participants in this group will receive two doses (IM) of RAZI recombinant spike protein vaccine 21 days apart followed by a 10 \u03bcg\u2044200\u03bcl nasal spray 51 days after the first dose (day 0)", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}, {"arm_notes": "5 \u03bcg\u2044200\u03bcl ", "treatment_id": 1066, "treatment_name": "Razi cov pars", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "10 \u03bcg\u2044200\u03bcl", "treatment_id": 1066, "treatment_name": "Razi cov pars", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "20 \u03bcg\u2044200\u03bcl", "treatment_id": 1066, "treatment_name": "Razi cov pars", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}]